During the past decade, Csongrad Megyei Dr. Bugyi Istvan Korhaz conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 16 clinical trials were completed, i.e. on average, 64% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Csongrad Megyei Dr. Bugyi Istvan Korhaz" #1 sponsor was "Shire" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Celgene" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Csongrad Megyei Dr. Bugyi Istvan Korhaz" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Csongrad Megyei Dr. Bugyi Istvan Korhaz" are "Ulcerative Colitis" (6 trials), "Rheumatoid Arthritis" (4 trials), "Crohn Disease" (3 trials), "Heart Failure" (2 trials) and "Active Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Csongrad Megyei Dr. Bugyi Istvan Korhaz" in a lesser frequency.

Most popular intervention types in "Csongrad Megyei Dr. Bugyi Istvan Korhaz" are "Drug" (26 trials), "Other" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Ozanimod" (3 trials), "Empagliflozin" (2 trials), "Etrolizumab" (2 trials) and "Filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Csongrad Megyei Dr. Bugyi Istvan Korhaz" are 25 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Csongrad Megyei Dr. Bugyi Istvan Korhaz". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Csongrad Megyei Dr. Bugyi Istvan Korhaz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Csongrad Megyei Dr. Bugyi Istvan Korhaz, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".